Idarucizumab
Records for this ingredient, by country (identity only).
ATC V03AB37 · 12 markets · 13 records
AU 2 records · 1 shown of 1
- 2,500 mg per mL / per unit basis not statedinjectionPRAXBIND idarucizumab (rch) 50 mg/ml solution for injection/infusion vial
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
US 1 records · 1 shown of 1
- 50 mg per mL / per unit basis not statedinjectionPraxbind
GB 1 records · 1 shown of 1
- 2,500 mg/50 mLinjectionPraxbind 2.5g/50ml solution for infusion vials
CA 1 records · 1 shown of 1
- 50 mg per mL / per unit basis not statedliquidPraxbind
SG 1 records · 1 shown of 1
- 50 mg/mL per mL / per unit basis not statedinjectionPRAXBIND SOLUTION FOR INJECTION/INFUSION 50 MG/ML
ES 1 records · 1 shown of 1
- 50 mg/1 mLinjectionPraxbind
TW 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
HK 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
JP 1 records · 1 shown of 1
- 2500 mg/50 mLinjectionプリズバインド静注液2.5g
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 1 records · 1 shown of 1
- 50 mg/1 mLinjectionPRAXBIND 2,5 g/50 ml, solution injectable/pour perfusion
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.